If you’re considering investing in marijuana stocks, it’s important to know some of the unique risks associated with the marijuana industry including scams.
I don’t think I’ve ever written an article that had so many opportunities for pun placement, but I held back because risky investments are no laughing matter (as a huge fan of puns, I couldn’t resist some of the temptation). This industry has been called the wild west of investing, littered with overvalued companies and scams. Despite the high risks, many investors are wondering if they should be investing in marijuana stocks.
Anytime you invest you need to know what you’re getting into and, as always, do your research. There are unique differences between investing in this budding industry and more established ones. If you’re set on investing in this space, it’s a good idea to know the warning signs of scams, differences between federal and state laws in the United States, and what’s going on with legalization in Canada. You might also be interested in learning about one area that isn’t operating in violation of federal laws.
When FINRA—the organization authorized by Congress to protect America’s investors—finds it necessary to issue Investor Alerts on marijuana stock scams, alarm bells should be ringing. Still not shying away? Well, be sure to also check out the U.S. Securities and Exchange Commission’s Investor Alert on marijuana-related investments.
According to the SEC, “fraudsters often exploit the latest innovation, technology, product, or growth industry—in this case, marijuana—to lure investors with the promise of high returns”. Many marijuana companies are penny stocks trading on over-the-counter, or OTC, markets. For the most part, there is limited publicly-available information on these companies and the SEC warns investors to be cautious if these red flags are present:
FIGURE 1: WHEN THE SEC CHARGES A COMPANY WITH FRAUD.
Investors in Fusion Pharm (FSPM), once a hot marijuana stock, lost virtually all of their money after the Securities and Exchange Commission suspended trading in the stock and charged the company and its officers for violating registration and antifraud provisions of the federal securities laws. Chart source: thinkorswim® by TD Ameritrade. Data source: Standard & Poor’s. Not a recommendation. For illustrative purposes only. Past performance does not guarantee future results.
Eight states and Washington D.C. have legalized the recreational use of marijuana, and 44 states have laws governing medicinal use. Laws vary from state to state, which adds complexities that can result in companies or individuals violating state production and distribution laws. An even greater source of uncertainty for companies is that all these activities are illegal under federal law because marijuana is still a Schedule I substance under the Controlled Substances Act. The U.S. Drug Enforcement Administration defines Schedule I substances as “drugs with no currently accepted medical use and a high potential for abuse.” How are these companies getting away with it then?
Under the Obama administration, Attorney General James Cole issued a memo outlining the federal government’s priorities on marijuana enforcement. It instructed Justice Department attorneys and law enforcement to “focus their enforcement resources and efforts, including prosecution, on persons or organizations whose conduct interferes with any one or more of these priorities, regardless of state law”. You read that right, the Cole memo leaves the door open for federal enforcement, but these are the specific priorities the memo said the federal government should focus on preventing:
Canada legalized marijuana for medical use in 1999. Medical use faced tight regulations at first, but those have loosened over time. Now Prime Minister Justin Trudeau is following through on one of his campaign promises. He recently introduced legislation to legalize recreational marijuana use and, if all goes according to plan, the Canadian government hopes to allow legal sales by the middle of next year.
Canada’s proposed law requires purchasers to be at least 18 years old and limits the amount you can have to 30 grams, which is close to the recreational use amounts allowed in Colorado and California. The Canadian government will license and supervise commercial growers, similar to the current regulations they have in place for the cultivation of medical marijuana. The proposed law would eliminate certain legal risks for Canadian companies that American companies are still exposed to.
There are pharmaceutical companies developing cannabis-based treatments for a variety of uses. Several have developed marijuana-based treatments that have been approved by the Food and Drug Administration (FDA), and others are in the process. These companies operate legally under federal and state laws, with stocks listed on major exchanges with strict reporting requirements.
At the end of the day, only you can decide what to invest in. If you’re considering investing in marijuana stocks, do your homework and research the company as much as possible. Thorough research might help you avoid investing in a sham company that could result in you losing your entire investment. If you’re having doubts, it might be a good idea to wait until the industry has matured.
for thinkMoney ®
Financial Communications Society 2016
for Ticker Tape
Content Marketing Awards 2016
All investing involves risks, including loss of
Market volatility, volume, and system availability may delay account access and trade executions.
Past performance of a security or strategy does not guarantee future results or success.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. Options trading subject to TD Ameritrade review and approval. Please read Characteristics and Risks of Standardized Options before investing in options.
Supporting documentation for any claims, comparisons, statistics, or other technical data will be supplied upon request.
The information is not intended to be investment advice or construed as a recommendation or endorsement of any particular investment or investment strategy, and is for illustrative purposes only. Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade. Clients must consider all relevant risk factors, including their own personal financial situations, before trading.
This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.
TD Ameritrade, Inc., member FINRA/SIPC. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. © 2018 TD Ameritrade.